Cite
HARVARD Citation
Chi, X. et al. (2022). BOB: Bayesian optimal design for biosimilar trials with co‐primary endpoints. Statistics in medicine. pp. 5319-5334. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Chi, X. et al. (2022). BOB: Bayesian optimal design for biosimilar trials with co‐primary endpoints. Statistics in medicine. pp. 5319-5334. [Online].